Literature DB >> 20175028

Two decades of advances in hepatocellular carcinoma research.

Jordi Bruix1, Josep M Llovet.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20175028     DOI： 10.1055/s-0030-1247219

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  10 in total

Review 1.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

2.  Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.

Authors:  Hai-Hong Ye; Jia-Zhou Ye; Zhi-Bo Xie; Yu-Chong Peng; Jie Chen; Liang Ma; Tao Bai; Jun-Ze Chen; Zhan Lu; Hong-Gui Qin; Bang-De Xiang; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

3.  Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.

Authors:  Ta-Chiang Liu; Neeta Vachharajani; William C Chapman; Elizabeth M Brunt
Journal:  Mod Pathol       Date:  2013-09-20       Impact factor: 7.842

4.  Presentation and outcomes of hepatocellular carcinoma patients at a western centre.

Authors:  Krit Kitisin; Vignesh Packiam; Jennifer Steel; Abhinav Humar; T Clark Gamblin; David A Geller; J Wallis Marsh; Allan Tsung
Journal:  HPB (Oxford)       Date:  2011-08-11       Impact factor: 3.647

5.  Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States.

Authors:  Jessica A Davila; Zhigang Duan; Katherine A McGlynn; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2012-01       Impact factor: 3.062

6.  SALL4 immunoreactivity predicts prognosis in Western hepatocellular carcinoma patients but is a rare event: a study of 236 cases.

Authors:  Ta-Chiang Liu; Neeta Vachharajani; William C Chapman; Elizabeth M Brunt
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

7.  Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.

Authors:  Jia-Zhou Ye; Yong-Quan Zhang; Hai-Hong Ye; Tao Bai; Liang Ma; Bang-De Xiang; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization.

Authors:  Azadeh Poursaid; Robert Price; Andrea Tiede; Erik Olson; Eugene Huo; Lawrence McGill; Hamidreza Ghandehari; Joseph Cappello
Journal:  Biomaterials       Date:  2015-04-28       Impact factor: 12.479

9.  Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes.

Authors:  Ryan Z Swan; David Sindram; John B Martinie; David A Iannitti
Journal:  J Gastrointest Surg       Date:  2013-02-13       Impact factor: 3.452

10.  N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells.

Authors:  Liliia M Kril; Valery Vilchez; Jieyun Jiang; Lilia Turcios; Changguo Chen; Vitaliy M Sviripa; Wen Zhang; Chunming Liu; Brett Spear; David S Watt; Roberto Gedaly
Journal:  Bioorg Med Chem Lett       Date:  2015-07-26       Impact factor: 2.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.